|
1
|
Puig L: Cardiometabolic comorbidities in
psoriasis and psoriatic arthritis. Int J Mol Sci.
19(58)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Jensen P and Skov L: Psoriasis and
obesity. Dermatology. 232:633–639. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Batani A, Brănișteanu DE, Ilie MA, Boda D,
Ianosi S, Ianosi G and Caruntu C: Assessment of dermal papillary
and microvascular parameters in psoriasis vulgaris using in
vivo reflectance confocal microscopy. Exp Ther Med.
15:1241–1246. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Maranduca MA, Hurjui LL, Branisteanu DC,
Serban DN, Branisteanu DE, Dima N and Serban IL: Skin-a vast organ
with immunological function (review). Exp Ther Med. 20:18–23.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Grechin C, Solovăstru LG, Vâță D, Pătrașcu
AI, Grăjdeanu AI and Andrese-Porumb E: Inflammatory marker
alteration in response to systemic therapies in psoriasis. Exp Ther
Med. 20:42–46. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gottlieb AB and Dann F: Comorbidities in
patients with psoriasis. Am J Med. 122:1150.e1–1150.e9.
2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Porumb-Andrese E, Vâță D, Postolică R,
Stătescu L, Stătescu C, Grăjdeanu AI, Pătrașcu AI, Popescu IA and
Solovastru LG: Association between personality type, affective
distress profile and quality of life in patients with psoriasis vs.
patients with cardiovascular disease. Exp Ther Med. 18:4967–4973.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Alsufyani MA, Golant AK and Lebwohl M:
Psoriasis and the metabolic syndrome. Dermatol Ther. 23:137–143.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Elmets CA, Leonardi CL, Davis DM, Gelfand
JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM,
Elewski BE, et al: Joint AAD-NPF guidelines of care for the
management and treatment of psoriasis with awareness and attention
to comorbidities. J Am Acad Dermatol. 80:1073–1113. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sterry W, Strober BE and Menter A: Obesity
in psoriasis: The metabolic, clinical and therapeutic implications.
Report of an interdisciplinary conference and review. Br J
Dermatol. 157:649–655. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gisondi P, Bellinato F, Girolomoni G and
Albanesi C: Pathogenesis of chronic plaque psoriasis and its
intersection with cardio-metabolic comorbidities. Front. Pharmacol.
11(117)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Puig L, Kirby B, Mallbris L and Strohal R:
Psoriasis beyond the skin: A review of the literature on
cardiometabolic and psychological co-morbidities of psoriasis. Eur
J Dermatol. 24:305–311. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lønnberg AS, Skov L, Skytthe A, Kyvik KO,
Pedersen OB and Thomsen SF: Association of psoriasis with the risk
for type 2 diabetes mellitus and obesity. JAMA Dermatol.
152:761–767. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Armstrong AW, Harskamp CT and Armstrong
EJ: The association between psoriasis and obesity: A systematic
review and meta-analysis of observational studies. Nutr Diabetes.
2(e54)2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ghiasi M, Nouri M, Abbasi A, Hatami P,
Abbasi MA and Nourijelyani K: Psoriasis and increased prevalence of
hypertension and diabetes mellitus. Indian J Dermatol. 56:533–536.
2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shapiro J, Cohen AD, David M, Hodak E,
Chodik G, Viner A, Kremer E and Heymann A: The association between
psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case
control study. J Am Acad Dermatol. 56:629–634. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Granata M, Skarmoutsou E, Trovato C, Rossi
GA, Mazzarino MC and D'Amico F: Obesity, type 1 diabetes, and
psoriasis: An autoimmune triple flip. Pathobiology. 84:71–79.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cohen AD, Sherf M, Vidavsky L, Vardy DA,
Shapiro J and Meyerovitch J: Association between psoriasis and the
metabolic syndrome. A cross-sectional study. Dermatology.
216:152–155. 2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bartosińska J, Przepiórka-Kosińska J,
Sarecka-Hujar B, Raczkiewicz D, Kowal M, Chyl-Surdacka K,
Bartosiński J, Kosiński J, Krasowska D and Chodorowska G:
Osteopontin serum concentration and metabolic syndrome in male
psoriatic patients. J Clin Med. 10(755)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Dai YX, Shen YJ, Chou YJ, Chang YT, Chen
TJ, Li CP and Wu CY: Obesity, but not metabolic diseases, is
associated with risk of psoriasis: A population-based cohort study
in taiwan. Dermatology. 236:521–528. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Owczarczyk-Saczonek A, Purzycka-Bohdan D,
Nedoszytko B, Reich A, Szczerkowska-Dobosz A, Bartosiñska J,
Batycka-Baran A, Czajkowski R, Dobrucki IT, Dobrucki LW, et al:
Pathogenesis of psoriasis in the ‘omic’ era. Part III. Metabolic
disorders, metabolomics, nutrigenomics in psoriasis in psoriasis.
Postepy Dermatol Alergol. 37:452–467. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yamazaki F: Psoriasis: Comorbidities. J
Dermatol. 48:732–740. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brazzelli V, Maffioli P, Bolcato V, Ciolfi
C, D'Angelo A, Tinelli C and Derosa G: Psoriasis and diabetes, a
dangerous association: Evaluation of insulin resistance, lipid
abnormalities, and cardiovascular risk biomarkers. Front Med
(Lausanne). 8(605691)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Brănişteanu DE, Voicu CM, Creţu A,
Dimitriu A, Luca MC and Sălăvăstru CM: Adverse reactions of
biological therapy for psoriasis. Rev Med Chir Soc Med Nat Iasi.
119:38–44. 2015.PubMed/NCBI
|
|
25
|
Committee of the Japan Diabetes Society on
the Diagnostic Criteria of Diabetes Mellitus. Seino Y, Nanjo K,
Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N,
Iwamoto Y, et al: Report of the committee on the classification and
diagnostic criteria of diabetes mellitus. J Diabetes Investig.
1:212–228. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Radtke MA, Mrowietz U, Feuerhahn J, Härter
M, von Kiedrowski R, Nast A, Reich K, Strömer K, Wohlrab J and
Augustin M: Early detection of comorbidity in psoriasis:
recommendations of the national conference on healthcare in
psoriasis. J Dtsch Dermatol Ges. 13:674–690. 2015.PubMed/NCBI View Article : Google Scholar : (In English,
German).
|
|
27
|
Armstrong AW, Harskamp CT and Armstrong
EJ: Psoriasis and the risk of diabetes mellitus. JAMA Dermatol.
149:84–91. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li W, Han J, Hu FB, Curhan GC and Qureshi
AA: Psoriasis and risk of type 2 diabetes among women and men in
the United States: A population-based cohort study. J Invest
Dermatol. 132:291–298. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tula E, Ergun T, Seckin D, Ozgen Z and
Avsar E: Psoriasis and the liver: Problems, causes and course.
Australas J Dermatol. 58:194–199. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gisondi P, Targher G, Zoppini G and
Girolomoni G: Non-alcoholic fatty liver disease in patients with
chronic plaque psoriasis. J Hepatol. 51:758–764. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Van der Voort EA, Koehler EM, Dowlatshahi
EA, Hofman A, Stricker BH, Janssen HLA, Schouten JNL and Nijsten T:
Psoriasis is independently associated with nonalcoholic fatty liver
disease in patients 55 years old or older: Results from a
population-based study. J Am Acad Dermatol. 70:517–524.
2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gisondi P, Ferrazzi A and Girolomoni G:
Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat.
18:297–304. 2010.PubMed/NCBI
|
|
33
|
Ghafoor R, Rashid A and Anwar MI:
Dyslipidemia and psoriasis: A case control study. J Coll Physicians
Surg Pak. 25:324–327. 2015.PubMed/NCBI
|
|
34
|
Mocanu M, Toader MP, Rezus E and Taranu T:
Aspects concerning patient adherence to anti-TNFα therapy in
psoriasis: A decade of clinical experience. Exp Ther Med.
18:4987–4992. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Grundy SM, Brewer HB Jr, Cleeman JI, Smith
SC Jr and Lenfant C: American Heart Association, National Heart,
Lung and Blood Institute. Definition of metabolic syndrome: Report
of the national heart, lung, and blood institute/American heart
association conference on scientific issues related to definition.
Circulation. 109:433–438. 2004.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Elgendy A, Alshawadfy E, Altaweel A and
Elsaidi A: Cardiovascular and metabolic comorbidities of psoriasis.
Dermatol Case Rep. 1(106)2016.
|
|
37
|
Gisondi P, Tessari G, Conti A, Piaserico
S, Schianchi S, Peserico A, Giannetti A and Girolomoni G:
Prevalence of metabolic syndrome in patients with psoriasis: A
hospital-based case-control study. Br J Dermatol. 157:68–73.
2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Singh S, Young P and Armstrong AW:
Relationship between psoriasis and metabolic syndrome: A systematic
review. G Ital Dermatol Venereol. 151:663–677. 2016.PubMed/NCBI
|
|
39
|
Goldminz AM, Buzney CD, Kim N, Au SC,
Levine DE, Wang AC, Volf EM, Yaniv SS, Kerensky TA, Bhandarkar M,
et al: Prevalence of the metabolic syndrome in children with
psoriatic disease. Pediatr Dermatol. 30:700–705. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gisondi P, Fostini AC, Fossà I, Girolomoni
G and Targher G: Psoriasis and the metabolic syndrome. Clin
Dermatol. 36:21–28. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wolk K, Mallbris L, Larsson P, Rosenblad
A, Vingård E and Ståhle M: Excessive body weight and smoking
associates with a high risk of onset of plaque psoriasis. Acta Derm
Venereol. 89:492–497. 2009.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Von Stebut E, Boehncke WH, Ghoreschi K,
Gori T, Kaya Z, Thaci D and Schäffler A: IL-17A in psoriasis and
beyond: Cardiovascular and metabolic implications. Front Immunol.
10(3096)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Gottlieb AB, Chao C and Dann F: Psoriasis
comorbidities. J Dermatolog Treat. 19:5–21. 2008.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lynde CW, Poulin Y, Vender R, Bourcier M
and Khalil S: Interleukin 17A: Toward a new understanding of
psoriasis pathogenesis. J Am Acad Dermatol. 71:141–150.
2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wolk K and Sabat R: Adipokines in
psoriasis: An important link between skin inflammation and
metabolic alterations. Rev Endocr Metab Disord. 17:305–317.
2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Dauden E, Blasco AJ, Bonanad C, Botella R,
Carrascosa JM, González-Parra E, Jodar E, Joven B, Lázaro P,
Olveira A, et al: Position statement for the management of
comorbidities in psoriasis. J Eur Acad Dermatol Venereol.
32:2058–2073. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Takeshita J, Grewal S, Langan SM, Mehta
NN, Ogdie A, Van Voorhees AS and Gelfand JM: Psoriasis and comorbid
diseases. Epidemiology. J Am Acad Dermatol. 76:377–390.
2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Langan SM, Seminara NM, Shin DB, Troxel
AB, Kimmel SE, Mehta NN, Margolis DJ and Gelfand JM: Prevalence of
metabolic syndrome in patients with psoriasis: A population-based
study in the United Kingdom. J Invest Dermatol. 132:556–562.
2012.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Christophers E: Comorbidities in
psoriasis. Clin Dermatol. 25:529–534. 2007.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Korman NJ: Management of psoriasis as a
systemic disease: What is the evidence? Br J Dermatol. 182:840–848.
2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wohlrab J, Fiedler G, Gerdes S, Nast A,
Philipp S, Radtke MA, Thaçi D, Koenig W, Pfeiffer AF, Härter M and
Schön MP: Recommendations for detection of individual risk for
comorbidities in patients with psoriasis. Arch Dermatol Res.
305:91–98. 2013.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Ryan C and Kirby B: Psoriasis is a
systemic disease with multiple cardiovascular and metabolic
comorbidities. Dermatol Clin. 33:41–55. 2015.PubMed/NCBI View Article : Google Scholar
|
